BlossomHill Therapeutics, Inc. (NASDAQ:BLSM) Financings
Financings
| Raise | Date |
|---|---|
| Public offering of common stock Closed: US$168.3M raised · US$16 a share · J.P. Morgan +4 Dealers: J.P. Morgan (lead), Leerink Partners (lead), Guggenheim Securities (lead), LifeSci Capital (co-lead), H.C. Wainwright & Co. (co-lead) | Sep 18, 2026 |